Innoviva

NASDAQ INVA
$15.84 -0.27 -1.68%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 36 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.36B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

1.62B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.48
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

84.53M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

0.44 %

Upcoming events Innoviva

All events
No upcoming events scheduled

Stock chart Innoviva

Stock analysis Innoviva

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
7.51 8.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
2.02 25.38
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
7.99 4.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
1.26 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
25.78 9.54

Price change Innoviva per year

9.21$ 17.45$
Min Max

Summary analysis Innoviva

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Innoviva

Revenue and net income Innoviva

All parameters

Stock news Innoviva

All news

Innoviva Appoints Stephen Basso as Chief Financial Officer

Innoviva Appoints Stephen Basso as Chief Financial Officer

FDA Approves Innoviva's Bacterial Pneumonia Treatment

FDA Approves Innoviva's Bacterial Pneumonia Treatment

Innoviva Shares Rise 7% After Pneumonia Drug's Approval by FDA Committee

Innoviva Shares Rise 7% After Pneumonia Drug's Approval by FDA Committee

Innoviva Shares Halted as FDA Panel Reviews Sulbactam-Durlobactam >INVA

Innoviva Shares Halted as FDA Panel Reviews Sulbactam-Durlobactam >INVA

Innoviva Says FDA Accepts, Grants Priority Review for Infection Treatment SUL-DUR NDA

Innoviva Says FDA Accepts, Grants Priority Review for Infection Treatment SUL-DUR NDA

Theravance, Innoviva Shares Rise After Sale of Trelegy Ellipta Royalty Interest

Theravance, Innoviva Shares Rise After Sale of Trelegy Ellipta Royalty Interest

La Jolla Shares Take Flight on Takeover by Innoviva >LJPC

La Jolla Shares Take Flight on Takeover by Innoviva >LJPC

Innoviva to Buy La Jolla Pharmaceutical in $149M Deal >INVA LJPC

Innoviva to Buy La Jolla Pharmaceutical in $149M Deal >INVA LJPC

Innoviva to Buy Rest of Entasis for $2.20 a Share in Cash

Innoviva to Buy Rest of Entasis for $2.20 a Share in Cash

Entasis Shares Rise After Innoviva Raises Buyout Price to $2 a Share

Entasis Shares Rise After Innoviva Raises Buyout Price to $2 a Share

About company Innoviva

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
Address:
1350 Old Bayshore Highway, Burlingame, CA, United States, 94010
Company name: Innoviva
Issuer ticker: INVA
ISIN: US45781M1018
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2004-10-05
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.inva.com

On which stock exchange are Innoviva (INVA) stocks traded?

Innoviva (INVA) stocks are traded on NASDAQ.

What is the ticker of Innoviva stocks (INVA)?

The stock ticker of Innoviva’s stocks or in other words, the code is INVA. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Innoviva (INVA) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Innoviva (INVA) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Innoviva (INVA) stocks traded?

Innoviva (INVA) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Innoviva (INVA) stocks today?

The current price of Innoviva stocks on 16.05.2024 is 15.84 dollars. per share.

What is the dynamics of Innoviva (INVA) stocks from the beginning of the year?

Innoviva (INVA) quotes have increased by -3.24% from the beginning of the year up to 15.84 dollars. per 1 stocks.

How much did Innoviva (INVA) stocks increase in мае 2024?

This month Innoviva (INVA) quotes have increased by 4.01% to 15.84 dollars. per share.

How much are Innoviva (INVA) stocks worth?

Today, on October, 16.05.2024 Innoviva’s (INVA) stocks cost 15.84 dollars..

What is the market capitalization of Innoviva (INVA)?

Capitalization is the market value of Innoviva (INVA) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 16.05.2024, the market capitalization of Innoviva (INVA) is estimated at about 1361794410 dollars.